Major advances in the treatment of multiple myeloma in American Society of Hematology annual meeting 2020
Treatment of multiple myeloma (MM) has advanced dramatically in the past two decades. However, under the conditions of the COVID-19 pandemic, treatment strategies have been modified accordingly. Numerous novel agents, updated trials, and major advances in myeloma have been reported in the American S...
Guardado en:
Autores principales: | Jianhua Du, Junling Zhuang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0cde6c5d687d4dfb96f5f89bf86d6846 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
por: Malkan Umit Yavuz, et al.
Publicado: (2021) -
Cytokine Release Syndrome in the Immunotherapy of Hematological Malignancies: The Biology behind and Possible Clinical Consequences
por: Tor Henrik Anderson Tvedt, et al.
Publicado: (2021) -
Mieloma múltiple en Chile: pasado, presente y futuro del programa nacional de drogas antineoplásicas (PANDA). Revisión de 1.103 pacientes
por: Peña,Camila, et al.
Publicado: (2018) -
High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience
por: Nikita E. Mochkin, et al.
Publicado: (2020) -
Study on the Relationship Between the Expression of B Cell Mature Antigen and the Classification, Stage, and Prognostic Factors of Multiple Myeloma
por: Tiantian Ma, et al.
Publicado: (2021)